Exact Mass: 397.1031

Exact Mass Matches: 397.1031

Found 26 metabolites which its exact mass value is equals to given mass value 397.1031, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Rivoglitazone

5-({4-[(6-methoxy-1-methyl-1H-1,3-benzodiazol-2-yl)methoxy]phenyl}methyl)-1,3-thiazolidine-2,4-dione

C20H19N3O4S (397.1096)


C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98241 - Thiazolidinedione Antidiabetic Agent

   

4-Hydroxy-5-[[4-[(6-methoxy-1-methylbenzimidazol-2-yl)methoxy]phenyl]methyl]-3H-1,3-thiazol-2-one

4-hydroxy-5-({4-[(6-methoxy-1-methyl-1H-1,3-benzodiazol-2-yl)methoxy]phenyl}methyl)-2,3-dihydro-1,3-thiazol-2-one

C20H19N3O4S (397.1096)


   

Dragmacidonamine B

Dragmacidonamine B

C19H17N4O4S (397.097)


   

S-adenosyl-4-methylsulfanyl-2-oxobutanoate

S-adenosyl-4-methylsulfanyl-2-oxobutanoate

C15H19N5O6S (397.1056)


   
   
   

S-adenosyl-4-methylthio-2-oxobutanoate

S-adenosyl-4-methylthio-2-oxobutanoate

C15H19N5O6S (397.1056)


A sulfonium betaine that is the conjugate base of S-adenosyl-4-methylthio-2-oxobutanoic acid, arising from deprotonation of the carboxy group.

   
   

4-((2-(5-CHLORO-2-FLUOROPHENYL)-6,7-DIHYDRO-5H-CYCLOPENTA[D]PYRIMIDIN-4-YL)AMINO)-N-METHYLNICOTINAMIDE

4-((2-(5-CHLORO-2-FLUOROPHENYL)-6,7-DIHYDRO-5H-CYCLOPENTA[D]PYRIMIDIN-4-YL)AMINO)-N-METHYLNICOTINAMIDE

C20H17ClFN5O (397.1106)


   

4-(4-Methoxy-4-biphenylylsulfonylaminomethyl)benzoic acid

4-(4-Methoxy-4-biphenylylsulfonylaminomethyl)benzoic acid

C21H19NO5S (397.0984)


   

5-[(4-Phenyl-1-piperazinyl)-thiophen-2-ylmethyl]-6-thiazolo[3,2-b][1,2,4]triazolol

5-[(4-Phenyl-1-piperazinyl)-thiophen-2-ylmethyl]-6-thiazolo[3,2-b][1,2,4]triazolol

C19H19N5OS2 (397.1031)


   

2-[[3-(2,5-dioxopyrrolidin-1-yl)benzoyl]amino]-N-methyl-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide

2-[[3-(2,5-dioxopyrrolidin-1-yl)benzoyl]amino]-N-methyl-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide

C20H19N3O4S (397.1096)


   

8-hydroxy-N-(3-(imidazo[1,2-a]pyridin-2-yl)phenyl)-2-oxo-2H-chromene-3-carboxamide

8-hydroxy-N-(3-(imidazo[1,2-a]pyridin-2-yl)phenyl)-2-oxo-2H-chromene-3-carboxamide

C23H15N3O4 (397.1063)


   

Rivoglitazone

Rivoglitazone

C20H19N3O4S (397.1096)


C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98241 - Thiazolidinedione Antidiabetic Agent

   

4-[(5-Adenosyl)(methyl)sulfonio]-2-oxobutanoate

4-[(5-Adenosyl)(methyl)sulfonio]-2-oxobutanoate

C15H19N5O6S (397.1056)


   

1-(3,4-Dihydroxyphenyl)-2-[[5-(2-methoxyphenyl)-4-prop-2-enyl-1,2,4-triazol-3-yl]thio]ethanone

1-(3,4-Dihydroxyphenyl)-2-[[5-(2-methoxyphenyl)-4-prop-2-enyl-1,2,4-triazol-3-yl]thio]ethanone

C20H19N3O4S (397.1096)


   

2-(8-methoxy-2-methyl-quinolin-4-yl)sulfanyl-N-[(E)-(2-oxidanyl-4-oxidanylidene-cyclohexa-2,5-dien-1-ylidene)methyl]ethanehydrazide

2-(8-methoxy-2-methyl-quinolin-4-yl)sulfanyl-N-[(E)-(2-oxidanyl-4-oxidanylidene-cyclohexa-2,5-dien-1-ylidene)methyl]ethanehydrazide

C20H19N3O4S (397.1096)


   

1-(3,4-Dihydroxyphenyl)-2-[[5-(3-methoxyphenyl)-4-prop-2-enyl-1,2,4-triazol-3-yl]thio]ethanone

1-(3,4-Dihydroxyphenyl)-2-[[5-(3-methoxyphenyl)-4-prop-2-enyl-1,2,4-triazol-3-yl]thio]ethanone

C20H19N3O4S (397.1096)


   

[4-(2-benzimidazolylidene)-3-imino-2-phenyl-1H-pyridazin-6-yl]-thiophen-2-ylmethanone

[4-(2-benzimidazolylidene)-3-imino-2-phenyl-1H-pyridazin-6-yl]-thiophen-2-ylmethanone

C22H15N5OS (397.0997)


   

1-(3,4-Dihydroxyphenyl)-2-[[5-(4-methoxyphenyl)-4-prop-2-enyl-1,2,4-triazol-3-yl]thio]ethanone

1-(3,4-Dihydroxyphenyl)-2-[[5-(4-methoxyphenyl)-4-prop-2-enyl-1,2,4-triazol-3-yl]thio]ethanone

C20H19N3O4S (397.1096)


   

Benoxathian (hydrochloride)

Benoxathian (hydrochloride)

C19H24ClNO4S (397.1114)


Benoxathian hydrochloride is a potent α1 adrenoceptor antagonist, can be used for researching anorexia[1].

   

HIF-1α-IN-2 (hydrochloride)

HIF-1α-IN-2 (hydrochloride)

C21H20ClN3OS (397.1016)


HIF-1α-IN-2 hydrochloride is an effective HIF-1α inhibitor with anticancer potencies (IC50s of 28 nM and 15 nM in MDA-MB-231 and MiaPaCa-2 cells, respectively). HIF-1α-IN-2 hydrochloride suppresses HIF-1α expression by blocking transcription and protein translation[1].

   

Sipagladenant

Sipagladenant

C20H19N3O4S (397.1096)


Sipagladenant (Compound I) is an orally active adenosine receptor A2A inverse agonist[1]. Sipagladenant can be used in frontal lobe dysfunction research[2].

   

4-{3-carboxy-6-hydroxy-9h-pyrido[3,4-b]indole-1-carbonyl}-1,3-dimethyl-5-(methylsulfanyl)-2h-imidazol-2-yl

4-{3-carboxy-6-hydroxy-9h-pyrido[3,4-b]indole-1-carbonyl}-1,3-dimethyl-5-(methylsulfanyl)-2h-imidazol-2-yl

C19H17N4O4S (397.097)


   

16-methyl-6,8,21,23-tetraoxa-16-azaheptacyclo[15.11.0.0²,¹⁴.0⁴,¹².0⁵,⁹.0¹⁸,²⁶.0²⁰,²⁴]octacosa-1(17),2(14),3,5(9),10,12,18(26),19,24,27-decaen-15-one

16-methyl-6,8,21,23-tetraoxa-16-azaheptacyclo[15.11.0.0²,¹⁴.0⁴,¹².0⁵,⁹.0¹⁸,²⁶.0²⁰,²⁴]octacosa-1(17),2(14),3,5(9),10,12,18(26),19,24,27-decaen-15-one

C24H15NO5 (397.095)


   

12-methyl-1,3-dioxo-4-phenyl-2-oxa-7,12-diazatetraphene-8-carboximidic acid

12-methyl-1,3-dioxo-4-phenyl-2-oxa-7,12-diazatetraphene-8-carboximidic acid

C23H15N3O4 (397.1063)